Two Sigma Securities, LLC Intra Cellular Therapies, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $340,098 - $545,088
-8,779 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $309,020 - $468,974
8,779 New
8,779 $459,000
Q4 2017

Feb 14, 2018
SELL
$14.27 - $16.79 $302,795 - $356,267
-21,219 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$10.77 - $22.1 $228,528 - $468,939
21,219
21,219 $335,000

Others Institutions Holding ITCI

# of Institutions
380
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email